BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYL-GLUTAMYL]-GAMMA-SARCOSINATE-DIESTER;ROTAMER-#2
Compound with spectra: 1 NMR
![BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYL-GLUTAMYL]-GAMMA-SARCOSINATE-DIESTER;ROTAMER-#2](/api/compound/DOweEmklyPW.png?ph=true&h=300&w=458 "BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYL-GLUTAMYL]-GAMMA-SARCOSINATE-DIESTER;ROTAMER-#2")
| SpectraBase Compound ID | DOweEmklyPW |
|---|---|
| InChI | InChI=1S/C21H30N2O7/c1-21(2,3)30-20(27)22-16(19(26)28-5)11-12-17(24)23(4)13-18(25)29-14-15-9-7-6-8-10-15/h6-10,16H,11-14H2,1-5H3,(H,22,27)/t16-/m0/s1 |
| InChIKey | RUORSQHLSIISOL-INIZCTEOSA-N |
| Mol Weight | 422.48 g/mol |
| Molecular Formula | C21H30N2O7 |
| Exact Mass | 422.205301 g/mol |
| Enantiomer InChIKey | RUORSQHLSIISOL-MRXNPFEDSA-N |
| Racemate InChIKey | RUORSQHLSIISOL-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
BENZYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINATE-DIESTER-HYDROCHLORIDE
(2S)-2-(tert-butoxycarbonylamino)-5-cyclopentyl-5-keto-valeric acid benzyl ester
(2S)-2-(tert-butoxycarbonylamino)-5-keto-5-phenyl-valeric acid benzyl ester
1,9-Dibenzyl 2(S),8(S)-Bis[((tert-butoxycarbonyl)amino]non-4-enedioate
(2S)-2-(tert-butoxycarbonylamino)-4-(4-nitrophenyl)butyric acid benzyl ester
Benzyl (2S,4R)-5-acetoy-2-[(tert-butoxycarbonyl)amino]-4-hydroxypentanoate
Benzyl 2(S)-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenyl-(E)-hex-5-enoate
N-CARBOXY-L-GLUTAMINE, N-BENZYL p-NITROPHENYL ESTER
BOC-L-leucine diphenylmethyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |